Obesity and Hypertension: Mechanisms, Cardio-Renal Consequences, and Therapeutic Approaches

被引：122

作者：

Reisin, Efrain ^{[1
]}

Jack, Avanelle V. ^{[1
]}

机构：

[1] Louisiana State Univ, Hlth Sci Ctr, Dept Med, Sect Nephrol & Hypertens, New Orleans, LA 70112 USA

来源：

MEDICAL CLINICS OF NORTH AMERICA | 2009年 / 93卷 / 03期

关键词：

Obesity; Hypertension; Renal and cardiovascular disease; Nonpharmacological and pharmacological therapies; LEFT-VENTRICULAR HYPERTROPHY; BLOOD-PRESSURE; WEIGHT-LOSS; METABOLIC SYNDROME; INSULIN-RESISTANCE; SALT RESTRICTION; KIDNEY-DISEASE; ADIPOSE-TISSUE; REDUCTION; OVERWEIGHT;

D O I：

10.1016/j.mcna.2009.02.010

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

Obesity and its relationship to hypertension is growing worldwide and is considered today to be a pandemic. This article focuses on the impact of obesity and hypertension on the cardiovascular and renal systems. It also summarizes the nonpharmacological and pharmacological approaches used to control hypertension in the obese population.

引用

收藏

页码：733 / +

页数：20

相关论文

共 110 条

[1]

Anand Rishi G, 2008, J Cardiometab Syndr, V3, P149, DOI 10.1111/j.1559-4572.2008.00003.x

[2]

[Anonymous], 1998, Obes Res, V6, p51S

[3]

A clinical trial of the effects of dietary patterns on blood pressure [J].

Appel, LJ ;

Moore, TJ ;

Obarzanek, E ;

Vollmer, WM ;

Svetkey, LP ;

Sacks, FM ;

Bray, GA ;

Vogt, TM ;

Cutler, JA ;

Windhauser, MM ;

Lin, PH ;

Karanja, N .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (16) :1117-1124

[4]

Artham Surya M, 2008, J Cardiometab Syndr, V3, P155, DOI 10.1111/j.1559-4572.2008.00001.x

[5]

Obesity-initiated metabolic syndrome and the kidney: A recipe for chronic kidney disease? [J].

Bagby, SP .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (11) :2775-2791

[6]

Differences in glucose tolerance between fixed-dose anti hypertensive drug combinations in people with metabolic syndrome [J].

Bakris, George ;

Molitch, Mark ;

Hewkin, Ann ;

Kipnes, Mark ;

Sarafidis, Pantelis ;

Fakouhi, Kaffa ;

Bacher, Peter ;

Sowers, James .

DIABETES CARE, 2006, 29 (12) :2592-2597

[7]

Differential effects of calcium antagonist subclasses on markers of nephropathy progression [J].

Bakris, GL ;

Weir, MR ;

Secic, M ;

Campbell, B ;

Weis-McNulty, A .

KIDNEY INTERNATIONAL, 2004, 65 (06) :1991-2002

[8]

HEMODYNAMIC ACTIONS OF INSULIN [J].

BARON, AD .

AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (02) :E187-E202

[9]

Weight maintenance, behaviors and barriers among previous participants of a university-based weight control program [J].

Befort, C. A. ;

Stewart, E. E. ;

Smith, B. K. ;

Gibson, C. A. ;

Sullivan, D. K. ;

Donnelly, J. E. .

INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 (03) :519-526

[10]

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity [J].

Benson, SC ;

Pershadsingh, HA ;

Ho, CI ;

Chittiboyina, A ;

Desai, P ;

Pravenec, M ;

Qi, NN ;

Wang, JM ;

Avery, MA ;

Kurtz, TW .

HYPERTENSION, 2004, 43 (05) :993-1002

← 1 2 3 4 5 6 7 8 9 10 →